Letter from Amanda Pritchard, NHS Chief Executive and Sir David Sloman, NHS Chief Operating Officer about stepping down the COVID-19 incident level.

This Patient Group Direction (PGD) is for the administration of COVID-19 vaccines to individuals aged 5 to 17 years, in accordance with the national COVID-19 vaccination programme.

This Patient Group Direction (PGD) is for the administration of COVID-19 vaccines to individuals 18 years and over, in accordance with the national COVID-19 vaccination programme.

Letter from Professor Sir Stephen Powis setting out next steps in transitioning to routine access for COVID treatments.

Classification: Official Publication reference: PR00337 27 March 2023 To: Integrated care board (ICB) chief medical officers (CMOs) ICB COVID therapeutics senior responsible officer (SROs) Regional chief pharmacists cc: Integrated care board: Directors of commissioning Chief operating officers Lead pharmacists Dear Colleagues, Transition of COVID treatments to routine pathways Thank you for the work you and […]

These schedules to the Standard Contract are for use by commissioners for non Primary-Care providers delivering COVID-19 vaccination services from April 2023.

A poster showing the process 111 teams must follow if a caller says they are eligible for antiviral treatment, have tested positive for COVID-19 and have not been contacted about treatment.

Letter from Sir James Mackey, National Director of Elective Recovery, NHS England and Prof Tim Briggs CBE, National Director of Clinical Improvement and Elective Recovery, NHS England.

The purpose of this commissioning framework is to support integrated care boards (ICBs) as commissioners of COVID-19 therapeutics for non-hospitalised patients who will benefit from them the most. This framework is intended to assist ICBs in establishing and maintaining timely access to COVID-19 therapeutics during the remainder of 2022/23 in preparation for routine provision from April 2023.